These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9625809)

  • 21. Alternative gonadotropin-releasing hormone processing products secreted from endometrial carcinoma.
    Takagi A; Imai A; Tamaya T
    Oncol Rep; 2000; 7(1):125-9. PubMed ID: 10601605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
    Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
    Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
    Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
    Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus].
    Yue Y; Piao JX; Wang LN; Pu JW; Gao FD
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
    Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
    Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacoperone IN3 enhances the apoptotic effect of leuprolide in prostate cancer cells by increasing the gonadotropin-releasing hormone receptor in the cell membrane.
    Sánchez CA; Mercado AJ; Contreras HR; Cabezas JC; Huidobro CC; Castellón EA
    Anticancer Drugs; 2012 Oct; 23(9):959-69. PubMed ID: 22713594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.
    Pappa EV; Zompra AA; Spyranti Z; Diamantopoulou Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
    Biopolymers; 2011; 96(3):260-72. PubMed ID: 20632397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
    Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.
    Engel JB; Hahne JC; Häusler SF; Meyer S; Segerer SE; Diessner J; Dietl J; Honig A
    Anticancer Res; 2012 May; 32(5):2063-8. PubMed ID: 22593489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
    Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
    Gynecol Oncol; 1994 Oct; 55(1):144-8. PubMed ID: 7959256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
    Katsila T; Balafas E; Liapakis G; Limonta P; Montagnani Marelli M; Gkountelias K; Tselios T; Kostomitsopoulos N; Matsoukas J; Tamvakopoulos C
    J Pharmacol Exp Ther; 2011 Mar; 336(3):613-23. PubMed ID: 21106905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin‑releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells.
    Teng LH; Ahmad M; Ng WT; Sabaratnam S; Rasan MI; Parhar I; Khoo AS
    Mol Med Rep; 2015 Oct; 12(4):4909-16. PubMed ID: 26151677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
    Imai A; Furui T; Tamaya T; Mills GB
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3370-5. PubMed ID: 10999836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction.
    Lama G; Papi M; Angelucci C; Maulucci G; Sica G; De Spirito M
    PLoS One; 2013; 8(1):e52530. PubMed ID: 23326338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
    Luo X; Xu J; Chegini N
    Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
    Chatzaki E; Bax CM; Eidne KA; Anderson L; Grudzinskas JG; Gallagher CJ
    Cancer Res; 1996 May; 56(9):2059-65. PubMed ID: 8616851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.